1887

Abstract

A formalin-inactivated respiratory syncytial virus vaccine was used to immunize infants in the mid-1960s; when these children later were naturally infected by the virus they developed markedly accentuated disease, and two died. For the present work, a new batch of vaccine was prepared using the original formula. Administration of either the old or new vaccines resulted in enhanced lesions in immunized cotton rats subsequently challenged with live virus, although administration of the vaccine reduced virus replication by 90%. Animals primed with formalin-inactivated virus and challenged developed markedly accentuated lesions of the same type as in animals undergoing primary or secondary infection. In addition, the animals with the vaccine-enhanced disease developed alveolitis and interstitial pneumonitis, which appear to be specific markers for the vaccine enhancement. The newly prepared vaccine appears suitable as a reference standard for studying the mechanism of vaccine-enhanced disease caused by this virus. Additionally, we reviewed the lesions in the lungs of the two humans who died with the vaccine-enhanced disease in 1967, and found that they were similar to, but more severe than those seen in the cotton rats.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-12-2881
2001-12-01
2019-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/12/0822881a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-12-2881&mimeType=html&fmt=ahah

References

  1. Aherne, W., Bird, T., Court, S. D. M., Gardner, P. S. & McQuillin, J. ( 1970; ). Pathological changes in virus infections of the lower respiratory tract in children. Journal of Clinical Pathology 23, 7-18.[CrossRef]
    [Google Scholar]
  2. Bembridge, G. P., Garcia-Beato, R., Lopez, J. A., Melero, J. A. & Taylor, G. ( 1998; ). Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein. Journal of Immunology 161, 2473-2480.
    [Google Scholar]
  3. Chin, J., Magoffin, R. L., Shearer, L. A., Schieble, J. H. & Lennette, E. H. ( 1969; ). Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. American Journal of Epidemiology 89, 449-463.
    [Google Scholar]
  4. Connors, M., Kulkarni, A. B., Firestone, C.-Y., Holmes, K. L., Morse, H. C., Sotnikov, A. V. & Murphy, B. R. ( 1992; ). Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. Journal of Virology 66, 7444-7451.
    [Google Scholar]
  5. Fulginiti, V. A., Eller, J. J., Downie, A. W. & Kempe, C. H. ( 1967; ). Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. Journal of the American Medical Association 202, 1075-1080.[CrossRef]
    [Google Scholar]
  6. Fulginiti, V. A., Eller, J. J., Sieber, O. F., Joyner, J. W., Minamitani, M. & Meiklejohn, G. ( 1969; ). Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. American Journal of Epidemiology 89, 435-448.
    [Google Scholar]
  7. Gershwin, J. L., Schelegle, E. S., Gunther, R. A., Anderson, M. L., Woolums, A. R., Larochelle, D. R., Boyle, G. A., Friebertshauser, K. E. & Singer, R. S. ( 1998; ). A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine 16, 1225-1236.[CrossRef]
    [Google Scholar]
  8. Hussell, T., Georgiou, A., Sparer, T. E., Matthews, S., Pala, P. & Openshaw, P. J. M. ( 1998; ). Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection. Journal of Immunology 161, 6215-6222.
    [Google Scholar]
  9. Johnson, K. J. & Ward, P. A. ( 1974; ). Acute immunologic pulmonary alveolitis. Journal of Clinical Investigation 54, 349-357.[CrossRef]
    [Google Scholar]
  10. Johnson, T. R., Johnson, J. E., Roberts, S. R., Wertz, G. W., Parker, R. A. & Graham, B. S. ( 1998; ). Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. Journal of Virology 72, 2871-2880.
    [Google Scholar]
  11. Kakuk, T. J., Soike, K., Brideau, R. J., Zaya, R. M., Cole, S. L., Zhang, J.-Y., Roberts, E. D., Wells, P. A. & Wathen, M. W. ( 1993; ). A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine. Journal of Infectious Diseases 167, 553-561.[CrossRef]
    [Google Scholar]
  12. Kapikian, A. Z., Mitchell, R. H., Chanock, R. M., Shvedoff, R. A. & Stewart, C. E. ( 1969; ). An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. American Journal of Epidemiology 89, 405-421.
    [Google Scholar]
  13. Kim, H. W., Canchola, J. G., Brandt, C. D., Pyles, G., Chanock, R. M., Jensen, K. & Parrott, R. H. ( 1969; ). Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89, 422-434.
    [Google Scholar]
  14. McIntosh, K. & Fishaut, J. M. ( 1980; ). Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Progress in Medical Virology 26, 94-118.
    [Google Scholar]
  15. Murphy, B. R., Prince, G. A., Lawrence, L. A., Croen, K. D. & Collins, P. L. ( 1990; ). Detection of respiratory syncytial virus (RSV) infected cells by in situ hybridization in the lungs of cotton rats immunized with formalin-inactivated virus or purified RSV F and G glycoprotein subunit vaccine and challenged with RSV. Virus Research 16, 153-162.[CrossRef]
    [Google Scholar]
  16. Piedra, P. A., Camussi, G. & Ogra, P. L. ( 1989 a; ). Immune response to experimentally induced infection with respiratory syncytial virus: possible role in the development of pulmonary disease. Journal of General Virology 70, 325-333.[CrossRef]
    [Google Scholar]
  17. Piedra, P. A., Faden, H. S., Camussi, G., Wong, D. T. & Ogra, P. L. ( 1989 b; ). Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus. Vaccine 7, 34-38.[CrossRef]
    [Google Scholar]
  18. Piedra, P. A., Wyde, P. R., Castleman, W. L., Ambrose, M. W., Jewell, A. M., Speelman, D. J. & Hildreth, S. W. ( 1993; ). Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine 11, 1415-1423.[CrossRef]
    [Google Scholar]
  19. Prince, G. A., Jenson, A. B., Horswood, R. L., Camargo, E. & Chanock, R. M. ( 1978; ). The pathogenesis of respiratory syncytial virus infection in cotton rats. American Journal of Pathology 93, 771-791.
    [Google Scholar]
  20. Prince, G. A., Prieels, J.-P., Slaoui, M. & Porter, D. D. ( 1999; ). Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus). Laboratory Investigation 79, 1385-1392.
    [Google Scholar]
  21. Prince, G. A., Jenson, A. B., Hemming, V. G., Murphy, B. R., Walsh, E. E., Horswood, R. L. & Chanock, R. M. ( 1986; ). Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by intramuscular inoculation of formalin-inactivated virus. Journal of Virology 57, 721-728.
    [Google Scholar]
  22. Sparer, T. E., Matthews, S., Hussell, T., Rae, A. J., Garcia-Barreno, B., Melero, J. A. & Openshaw, P. J. M. ( 1998; ). Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. Journal of Experimental Medicine 187, 1921-1926.[CrossRef]
    [Google Scholar]
  23. Tebbey, P. W., Hagen, M. & Hancock, G. E. ( 1998; ). Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. Journal of Experimental Medicine 188, 1967-1972.[CrossRef]
    [Google Scholar]
  24. Vaux-Peretz, F., Chapsal, J.-M. & Meignier, B. ( 1992; ). Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice. Vaccine 10, 113-118.[CrossRef]
    [Google Scholar]
  25. Waris, M. E., Tsou, C., Erdman, D. D., Zaki, S. R. & Anderson, L. J. ( 1996; ). Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. Journal of Virology 70, 2852-2860.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-12-2881
Loading
/content/journal/jgv/10.1099/0022-1317-82-12-2881
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error